April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Effect of Anti-Vascular Endothelial Growth Factor Antibody on the Differentiation of Retinoblastoma Cells
Author Affiliations & Notes
  • C. S. Cho
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • K.-W. Kim
    College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea
  • Y. Yu
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  C.S. Cho, None; J. Kim, None; K.-W. Kim, None; Y. Yu, None; J. Kim, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2663. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. S. Cho, J. Kim, K.-W. Kim, Y. Yu, J. Kim; Effect of Anti-Vascular Endothelial Growth Factor Antibody on the Differentiation of Retinoblastoma Cells. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2663. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate whether anti-vascular endothelial growth factor (VEGF) antibody affects the differentiation of retinoblastoma cells

Methods: : Human retinoblastoma cells, SNUOT-Rb1, were differentiated by treatment of 0.1% bovine serum albumin (BSA), and then treated by anti-VEGF antibody (Bevaxizumab) for 48 hours. To determine the differentiation of SNUOT-Rb1, the neurotrophin receptors (Trk A, Trk B) and the neuronal differentiation markers (Shank1, 2) were detected by Western blot analysis and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Furthermore, extracellular signal-regulated kinases 1 and 2 (ERK 1/2) phosphorylation was also detected.

Results: : Treatment of anti-VEGF antibody did not affect to cell viability, but attenuated neurite outgrowth of 0.1% BSA treated-retinoblastoma cells. mRNA of Shank 1 and 2 were decreased by anti-VEGF antibody treatment, which might be mediated by inhibition of ERK 1/2 phosphorylation. Furthermore, Trk A expression was decreased by anti-VEGF antibody treatment.

Conclusions: : Anti-VEGF antibody treatment might inhibit the differentiation of retinoblastoma cells. Therefore, anti-VEGF antibody should be careful to treat to the developing eyes, because of the effect of anti-VEGF antibody on neuronal differentiation.

Keywords: retinoblastoma • signal transduction • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×